J9298 Injection, nivolumab and relatlimab-rmbw, 3 mg/1 mg
Short descriptor: Inj nivol relatlimab 3mg/1mg
Look up J9298 alongside ICD-10-CM diagnoses, the HCPCS Table of Drugs, and the AI coding assistant.
J9298 is the HCPCS Level II code for Injection, nivolumab and relatlimab-rmbw, 3 mg/1 mg (2026). It belongs to Section J — Drugs Administered Other Than Oral Method. Under Medicare, its coverage status is: Carrier judgment. Part B pricing methodology: Drugs.
Classification & CMS Attributes
- Medicare Coverage
- Carrier judgment (code C)
- Part B Pricing
- Drugs (indicator 51)
- Type of Service
- Medical care
- Effective Date
- 2022-10-01
- 2026 Maintenance
- No change this year
Drug Details
- Drug / Substance
- nivolumab and relatlimab-rmbw
- Dose / Unit
- 3 mg/1 mg
- Route
- Injection
See the full HCPCS Table of Drugs (J-codes).
References
Cite This Page
Reference J9298 with the canonical source and edition:
J9298 — Injection, nivolumab and relatlimab-rmbw, 3 mg/1 mg. ICD-10 Coding Pro (HCPCS Level II 2026). https://icd10codingpro.com/hcpcs-codes/J9298
Canonical URL: https://icd10codingpro.com/hcpcs-codes/J9298